文献速递瓣膜病与结构性心脏病血脂与心血管预防

FADS1/2基因变异与多不饱和脂肪酸和主动脉瓣狭窄的关联

Association of FADS1/2 Locus Variants and Polyunsaturated Fatty Acids With Aortic Stenosis.
PubMed 文献 · JAMA Cardiol · 2020-01-01

结果发现FADS1/2位点rs174547变异与AS相关,meta分析达全基因组显著性;生物标志物和孟德尔随机化提示ω-6脂肪酸合成途径与AS相关,可能为治疗靶点。

要点

  • FADS1/2位点rs174547变异与AS风险降低相关,meta分析OR 0.91。
  • 花生四烯酸/亚油酸比值升高与主动脉瓣钙化(AVC)相关。
  • 孟德尔随机化提示FADS1肝脏表达和花生四烯酸升高与AS相关。

核心结论

  • FADS1/2位点变异与AS及AVC相关,ω-6脂肪酸生物合成途径可能为AS治疗靶点。

研究设计与样本

  • 另在CHARGE联盟6942名参与者中进行分析,并进行AVC生物标志物分析。

主要发现

  • GERA队列中rs174547变异与AS相关(每C等位基因OR 0.88,95%CI 0.83-0.93,P=3.0×10-6),与7个复制队列meta分析后达全基因组显著性(OR 0.91,95%CI 0.88-0.94,P=2.5×10-8)。
  • rs174547与AVC也呈一致关联(OR 0.91,95%CI 0.83-0.99,P=.03)。
  • 花生四烯酸/亚油酸比值升高与AVC相关(每SD自然对数OR 1.19,95%CI 1.09-1.30,P=6.6×10-5)。
  • 孟德尔随机化中,FADS1肝脏表达增加与AS相关(每单位标准化表达OR 1.31,95%CI 1.17-1.48,P=7.4×10-6)。
  • 花生四烯酸每增加5个百分点与AVC相关(OR 1.23,95%CI 1.01-1.49,P=.04),与AS相关(OR 1.08,95%CI 1.04-1.13,P=4.1×10-4)。

临床怎么用

  • FADS1/2变异和ω-6脂肪酸代谢标志物可能有助于AS风险分层,但尚需前瞻性验证。
  • ω-6脂肪酸合成途径作为AS药物靶点值得进一步研究,目前不推荐用于临床干预。

局限性

  • 研究以自报欧洲裔人群为主,结果外推需谨慎。
  • 病例对照设计不能完全确立因果关系,孟德尔随机化结果需实验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Aortic stenosis (AS) has no approved medical treatment. Identifying etiological pathways for AS could identify pharmacological targets. OBJECTIVE: To identify novel genetic loci and pathways associated with AS. DESIGN, SETTING, AND PARTICIPANTS: This genome-wide association study used a case-control design to evaluate 44 703 participants (3469 cases of AS) of self-reported European ancestry from the Genetic Epidemiology Research on Adult Health and Aging (GERA) cohort (from January 1, 1996, to December 31, 2015). Replication was performed in 7 other cohorts totaling 256 926 participants (5926 cases of AS), with additional analyses performed in 6942 participants from the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. Follow-up biomarker analyses with aortic valve calcium (AVC) were also performed. Data were analyzed from May 1, 2017, to December 5, 2019. EXPOSURES: Genetic variants (615 643 variants) and polyunsaturated fatty acids (ω-6 and ω-3) measured in blood samples. MAIN OUTCOMES AND MEASURES: Aortic stenosis and aortic valve replacement defined by electronic health records, surgical records, or echocardiography and the presence of AVC measured by computed tomography. RESULTS: The mean (SD) age of the 44 703 GERA participants was 69.7 (8.4) years, and 22 019 (49.3%) were men. The rs174547 variant at the FADS1/2 locus was associated with AS (odds ratio [OR] per C allele, 0.88; 95% CI, 0.83-0.93; P = 3.0 × 10-6), with genome-wide significance after meta-analysis with 7 replication cohorts totaling 312 118 individuals (9395 cases of AS) (OR, 0.91; 95% CI, 0.88-0.94; P = 2.5 × 10-8). A consistent association with AVC was also observed (OR, 0.91; 95% CI, 0.83-0.99; P = .03). A higher ratio of arachidonic acid to linoleic acid was associated with AVC (OR per SD of the natural logarithm, 1.19; 95% CI, 1.09-1.30; P = 6.6 × 10-5). In mendelian randomization, increased FADS1 liver expression and arachidonic acid were associated with AS (OR per unit of normalized expression, 1.31 [95% CI, 1.17-1.48; P = 7.4 × 10-6]; OR per 5-percentage point increase in arachidonic acid for AVC, 1.23 [95% CI, 1.01-1.49; P = .04]; OR per 5-percentage point increase in arachidonic acid for AS, 1.08 [95% CI, 1.04-1.13; P = 4.1 × 10-4]). CONCLUSIONS AND RELEVANCE: Variation at the FADS1/2 locus was associated with AS and AVC. Findings from biomarker measurements and mendelian randomization appear to link ω-6 fatty acid biosynthesis to AS, which may represent a therapeutic target.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Chen HY, Cairns BJ, Small AM, et al. Association of FADS1/2 Locus Variants and Polyunsaturated Fatty Acids With Aortic Stenosis. JAMA Cardiol. 2020. PMID: 32186652. doi:10.1001/jamacardio.2020.0246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。